WO2008083054A3 - Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure - Google Patents

Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure Download PDF

Info

Publication number
WO2008083054A3
WO2008083054A3 PCT/US2007/088495 US2007088495W WO2008083054A3 WO 2008083054 A3 WO2008083054 A3 WO 2008083054A3 US 2007088495 W US2007088495 W US 2007088495W WO 2008083054 A3 WO2008083054 A3 WO 2008083054A3
Authority
WO
WIPO (PCT)
Prior art keywords
imaging
adrenoreceptor
heart failure
congestive heart
instances
Prior art date
Application number
PCT/US2007/088495
Other languages
French (fr)
Other versions
WO2008083054A2 (en
Inventor
Ajay Purohit
Thomas D. Harris
Simon P. Robinson
Padmaja Yalamanchili
Michael T. Azure
David S. Casebier
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of WO2008083054A2 publication Critical patent/WO2008083054A2/en
Publication of WO2008083054A3 publication Critical patent/WO2008083054A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novel β1 adrenoreceptor ligands that find use as imaging agents within nuclear medicine applications (e.g., PET imaging and SPECT imaging) are provided. Methods of imaging, including methods of imaging congestive heart failure, are also provided. The novel compounds may exhibit high affinity and selectivity, minimal metabolism, minimal non-specific binding and have a favorable log P value (< 0). In some instances, β1-AR selective ligands are conjugated to an imaging moiety in such a way that it does not impact the antagonist affinity and their use. In other instances, the conjugation may be directly to the antagonist at several sites that will not impact affinity. In further instances, the conjugation may be by means of a linking group, which can be used to alter the pharmacokinetics and clearance of the complex.
PCT/US2007/088495 2006-12-26 2007-12-21 Ligands for cardiac beta1 adrenoceptor for imaging congestive heart failure WO2008083054A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87721006P 2006-12-26 2006-12-26
US60/877,210 2006-12-26

Publications (2)

Publication Number Publication Date
WO2008083054A2 WO2008083054A2 (en) 2008-07-10
WO2008083054A3 true WO2008083054A3 (en) 2010-01-28

Family

ID=39307948

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/088495 WO2008083054A2 (en) 2006-12-26 2007-12-21 Ligands for cardiac beta1 adrenoceptor for imaging congestive heart failure

Country Status (1)

Country Link
WO (1) WO2008083054A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012004549A1 (en) 2010-07-05 2012-01-12 The University Of Nottingham Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases
GB201101959D0 (en) 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease
GB201202613D0 (en) 2012-02-15 2012-03-28 Univ Nottingham Novel cyclic phenoxy compounds and improved treatments for cardiac and cardiovascular disease
CN106977426A (en) * 2017-05-27 2017-07-25 哈尔滨师范大学 A kind of anacardol phenylurea and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOPKA K ET AL: "Non-invasive molecular imaging of [beta]-adrenoceptors in vivo: Perspectives for PET-radioligands", CURRENT MEDICINAL CHEMISTRY 2005 NL, vol. 12, no. 18, 2005, pages 2057 - 2074, XP002544584, ISSN: 0929-8673 *
WAGNER, STEFAN ET AL: "Synthesis of an 18F-labeled high affinity .beta.1-adrenoceptor PET radioligand based on ICI 89,406", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS , 49(2), 177-195 CODEN: JLCRD4; ISSN: 0362-4803, 2006, XP002544585 *

Also Published As

Publication number Publication date
WO2008083054A2 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
Shonberg et al. Design strategies for bivalent ligands targeting GPCRs
WO2008083054A3 (en) Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure
EP2474523A3 (en) Ligands for imaging cardiac innervation
Spjut et al. A potent trivalent sialic acid inhibitor of adenovirus type 37 infection of human corneal cells
MA33702B1 (en) New Mitonzinoid and its use for the preparation of conjugates with antibodies
WO2006016276A3 (en) Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor
EP2253333A3 (en) Contrast Agents for Myocardial Perfusion Imaging
WO2007002540A3 (en) Radiolabeled-pegylation of ligands for use as imaging agents
WO2009129311A3 (en) Somatostatin receptor 2 antagonists
WO2004093908A3 (en) Compositions and methods for the therapy of inflammatory bowel disease
CA2361661A1 (en) Solid-state composition comprising solid particles and binder
TW200715050A (en) Photosensitive resin composition and photosensitive element using the same
JP2016506905A5 (en)
Katouah et al. Synthesis and docking study of pyrimidine derivatives scaffold for anti‐hypertension application
NO20051948L (en) Compounds that bind to leukocytes and medical composition containing the compound in the labeled state as active ingredient
Jones et al. Design and synthesis of a fluorescent muscarinic antagonist
EP1870396A4 (en) Benzyloxypropylamine derivative
EA200400070A1 (en) CHEMICALLY MODIFIED PROGENIPOETHINE CONJUGATES
小島有志 Study of radial particle transport induced by fluctuations using a gold neutral beam probe
Park et al. Anyword OCR in Ubiquitos Computing
JP2004307841A5 (en)
RU2003136901A (en) COMPOSITION FOR PRODUCING FIRE-RESISTANT TEXTILE MATERIALS
김지철 et al. The New Testament Society of Korea
SHAFIEI Potential Opponent for 18FDG: Gd3+-DTPA-DG: A New Synthetic MRI Contrast Agent
Stemplewski et al. Benchmarking to Developing an Image for the Sector\

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07869713

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07869713

Country of ref document: EP

Kind code of ref document: A2